ServiceShelton, CT, USAFounded 1967· One of 2012 Service companies tracked by AMPulse
Contract manufacturer specializing in Electron Beam Melting (EBM) 3D printing and precision CNC machining of patient-specific orthopedic and spinal implants.
CEO / Founder
Ronald F. Dunn (President at time of acquisition)
Team Size
51-200
Stage
Acquired
Total Funding
$15.8M
Latest Round
Acquired
Key Investors
Arcam AB (Acquirer)
Technology & Products
Key Products
Manufacturing and engineering services for surgical implant and instrument systems, specializing in orthopedic and spine markets. Combines EBM additive manufacturing with precision CNC machining for patient-specific implants.
Technological Advantage
CLAIMED: Hybrid manufacturing workflow integrating EBM 3D printing with 4/5-axis CNC machining for complex geometries. VERIFIED: Long-standing operational expertise in EBM process parameters for medical-grade titanium, validated through Arcam/GE Additive acquisition and integration into their medical manufacturing ecosystem. DEFENSIBLE: High switching cost due to specialized medical regulatory compliance (FDA/ISO 13485) and proprietary process know-how.
Differentiation
Value Proposition
Accelerates time-to-market for complex, patient-specific metal implants by combining EBM additive manufacturing with traditional machining, reducing surgical inventory costs and enabling rapid prototyping to full-scale production for medical device companies.
How They Differentiate
Unlike broad-service AM bureaus, DiSanto focuses exclusively on orthopedic/spine implants with a dedicated EBM + CNC hybrid workflow. Direct integration with Arcam/GE Additive provides optimized titanium EBM processes and hardware access that generalist competitors lack.
Market & Competition
Target Customers
Orthopedic and spinal implant OEMs, medical device manufacturers
Industry Verticals
Medical Devices; Orthopedics; Spine Surgery
Competitors
NuVasive, Onkos Surgical, CARLSMED
Growth & Milestones
Growth Metrics
Estimated annual revenue $12.4M–$17M; approximately 24–50 employees (per LeadIQ and RocketReach business intelligence data as of 2024/2025).
Major Milestones
1967: Company founded in Connecticut; 2013: Entered strategic partnership with Arcam AB for EBM technology; 2014: Acquired by Arcam AB to expand EBM-based orthopedic implant manufacturing
Notable Customers
Zimmer Biomet, Stryker, Medtronic, DePuy Synthes, Globus Medical
DiSanto Technology occupies a narrow but defensible niche: contract manufacturing of patient-specific orthopedic and spinal implants using electron beam melting (EBM) and precision CNC machining. Unlike broad-service additive manufacturing bureaus that serve prototyping or general production, DiSanto focuses exclusively on medical-grade titanium implants for spine and orthopedics, a segment where regulatory compliance and process repeatability create high switching costs.
The company's core workflow integrates Arcam EBM systems with 4/5-axis CNC machining, enabling complex lattice structures and porous surfaces for bone ingrowth alongside tight-tolerance machined features. This hybrid approach allows medical device OEMs to move from rapid prototyping to full-scale production without requalifying processes. DiSanto's long-standing operational expertise in EBM process parameters for medical-grade titanium was validated through its acquisition by Arcam AB in 2014, later folded into GE Additive and now part of Oerlikon Surface Solutions.
Named customers include Zimmer Biomet, Stryker, Medtronic, DePuy Synthes, and Globus Medical, reflecting deep integration with top orthopedic and spine OEMs. The company competes against NuVasive, Onkos Surgical, and CARLSMED, but differentiates through its exclusive focus on EBM for implants and direct access to Arcam/GE Additive hardware and process development. Estimated annual revenue ranges from $12.4 million to $17 million, with 24 to 50 employees as of 2024-2025.
A key strategic question is how DiSanto's position evolves under Oerlikon's broader surface solutions portfolio. While the parent company provides capital and global reach, DiSanto's value to OEMs has historically been its specialized, vertically integrated EBM-plus-machining workflow. Maintaining that focus within a larger industrial group will determine whether it retains its competitive edge against both dedicated implant manufacturers and expanding AM service bureaus.